Indivior Inc., a subsidiary of Indivior PLC INDV has reached an agreement to resolve the claims brought by the end payor class of litigants in the In re Suboxone Antitrust Litigation multi-district litigation. The agreement marks the resolution of the end payor claimants' claims against the company in the multi-district litigation. The agreement is subject to initial approval by the United States District Court for the Eastern District of Pennsylvania, a notice period, participation by an appropriate number of end payors and final approval of the court.
As part of the agreement, the company expects to pay $30 million to the end payor claimants. The settlement amount is in line with the current provision of $188 million for the multi-district litigation. Once the agreement is approved and entered by the court, the final settlement amount will be recorded against the $188 million provision. Payment into an escrow account for the benefit of the end payor claimants is expected to be made in September of 2023, and funded from the company's existing cash balance.
"We remain focused on helping those suffering from substance use disorders and mental illness," stated Mark Crossley, CEO. "Resolving these legacy legal matters at the right value helps us further our mission for patients and creates greater certainty for our stakeholders."
As set out in the company's half year report on July 27, 2023, the company continues to prepare for trial on October 30, 2023, in relation to the remaining claims of the direct purchaser class while at the same time exploring the possibility of settlement at the right value with this class.
Benzinga Cannabis Capital Conference
The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.
Photo by Scott Graham on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!